Publications found:
1,182
Sort by:
Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Pharmacologic Class (Angiogenesis Inhibitors, Monoclonal Antibodies, mTOR Inhibitors, Cytokine Immunotherapy (IL-2)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Kidney Cancer Drugs Market is projected for substantial growth, expanding from USD 7.27 Billion in 2025 to USD 10.62 Billion by 2031, reflecting a 6.52% CAGR. This market segment encompasse...
May 2026
180 pages
Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery), By End User (Ambulatory Surgery Centers, Hospitals and Specialty Clinics, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Gastric Cancer Therapy Market is projected to expand significantly, increasing from USD 4.15 Billion in 2025 to USD 6.11 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR)...
May 2026
185 pages
Radiotherapy Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), By Application (kin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Others), By End-User (Hospitals, Research Institutes, Ambulatory and Radiotherapy Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The global radiotherapy market is projected to expand from USD 6.81 billion in 2025 to USD 11.25 billion by 2031, growing at an 8.73% CAGR. Radiotherapy, a clinical method, uses ionizing radiation to...
May 2026
185 pages
Hairy Cell Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Targeted Therapy), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hairy Cell Leukemia Market is projected to experience substantial growth, expanding from USD 104.67 Billion in 2025 to USD 149.66 Billion by 2031, demonstrating a Compound Annual Growth Rat...
May 2026
185 pages
T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Peripheral {Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angio-immuno-blastic T-cell Lymphoma, Other}, Lymphoblastic), By Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The global T-Cell Lymphoma Market is projected to expand significantly, from USD 2.51 Billion in 2025 to USD 4.25 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 9.17%. T-cell l...
May 2026
180 pages
Bladder Cancer Therapeutics and Diagnostics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics (Chemotherapy, Immunotherapy, Other Therapeutics), By Diagnostics (Cystoscopy, Bladder Ultrasound, Urinalysis, Other Diagnostics), By Cancer Type (Transitional Cell Bladder Cancer, Squamous Cell Bladder Cancer, Other Cancer Types), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bladder Cancer Therapeutics and Diagnostics Market is projected to expand considerably, growing from USD 459.11 Million in 2025 to USD 711.71 Million by 2031, reflecting a 7.58% Compound An...
May 2026
192 pages
Bone Cancer Treatment Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Bone Cancer Type (Primary Bone Cancer, Secondary Bone Cancer), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bone Cancer Treatment Market is projected to expand significantly, growing from USD 1.42 Billion in 2025 to USD 1.93 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5...
May 2026
185 pages
Hepatoblastoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Alkylating Agent, Antibiotics, Vinca Alkaloids, Antimetabolites, Others), By Treatment (Surgery, Chemotherapy, Targeted Therapy, Radiation Therapy, Ablation Therapy, Others), By End User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hepatoblastoma Treatment Market is projected to expand significantly, growing from USD 369.98 Million in 2025 to USD 578.36 Million by 2031, demonstrating a compound annual growth rate (CAG...
May 2026
192 pages
Medullary Thyroid Cancer Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Treatment (Surgery, Radiation Therapy, Chemotherapy), By End-User (Hospitals, Radiation Therapy Center, Cancer Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Medullary Thyroid Cancer (MTC) is projected to expand significantly, increasing from USD 1.48 billion in 2025 to USD 2.42 billion by 2031, demonstrating a compound annual growth...
May 2026
180 pages
Metastatic Cancer Drugs Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Therapy Type (Chemotherapy, Immunotherapy, Hormone Therapy, Targeted Therapy, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Colorectal Cancer, Others), By End-User (Hospitals & Clinics, Ambulatory Centers, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for metastatic cancer drugs is projected to expand significantly, from USD 80.13 billion in 2025 to USD 123.53 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.48%. Thes...
May 2026
182 pages
Nuclear Medicine Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Alpha Emitters, Beta Emitters, and Brachytherapy), By Application (Oncology, Cardiology, Thyroid, and Other Applications), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Nuclear Medicine Therapeutics Market is projected for substantial growth, expanding from USD 998.12 million in 2025 to USD 1734.74 million by 2031, at a robust CAGR of 9.65%. This market le...
May 2026
185 pages
Pancreatic Cancer Therapeutics & Diagnostics Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Treatment {Targeted Therapies, Chemotherapy, Surgery, Other}, Diagnostics {Imaging, Biopsy, Endoscopic Ultrasound, Other}), By End-User (Hospital & Clinic, Ambulatory Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pancreatic Cancer Therapeutics & Diagnostics Market is projected to grow from USD 4.72 Billion in 2025 to USD 7.31 Billion by 2031, at a 7.56% CAGR. This market includes pharmaceutical trea...
May 2026
185 pages
Global Germ Cell Tumor Market Growth 2026-2032
US$ 3,660.00
The global Germ Cell Tumor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Germ cell tumors are derived from p...
May 2026
104 pages
Hedgehog Pathway Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Generic Drug (Glasdegib, Sonidegib, Vismodegib), By Dosage (Capsule and Injection), By End User (Homecare, Hospitals, Specialty Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hedgehog Pathway Inhibitors Market is projected to expand from USD 569.12 Million in 2025 to USD 862.75 Million by 2031, demonstrating a 7.18% CAGR. These targeted small molecule pharmaceut...
May 2026
182 pages
Neoantigen Targeted Therapies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Target Disease Indication (Bone Cancer, Colorectal Cancer, Gynecological Cancer, Non-Small Cell Lung Cancer, Renal Cell Carcinoma), By Neoantigens Type (Off-the-Shelf Neoantigens, Personalized Neoantigens), By Immunotherapy Type (Dendritic Cell Vaccines, DNA / RNA-Based Vaccines, Protein / Peptide-based Vaccines, TIL-Based Therapies), By Route of Administration (Intradermal, Intravenous, Subcutaneous), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Neoantigen Targeted Therapies Market is projected for substantial growth, anticipating an increase from USD 1.99 Billion in 2025 to USD 3.23 Billion by 2031, at an 8.41% Compound Annual Gro...
May 2026
180 pages
Pediatric Neuroblastoma Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), By End-User (Hospitals, Specialty Clinics and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pediatric Neuroblastoma Treatment Market is projected to grow from USD 1.59 Billion in 2025 to USD 2.62 Billion by 2031, at an 8.68% CAGR, encompassing therapeutic interventions like chemot...
May 2026
180 pages
Tumor Treatment Equipment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Surgical Equipment, Radiotherapy Equipment, Chemotherapy Equipment), By Application (Lung Cancer, Rectal Cancer, Breast Cancer, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for tumor treatment equipment, which includes specialized medical devices like radiotherapy systems and thermal ablation units used for the targeted destruction and management of mal...
May 2026
188 pages
Head and Neck Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Chemotherapy, Immunotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for head and neck cancer drugs is projected to expand significantly, rising from USD 2.02 billion in 2025 to USD 2.89 billion by 2031, at a compound annual growth rate of 6.15%. This...
May 2026
180 pages
Automated Compounding Device (Oncology) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Gravimetric Compounding System, Volumetric Compounding System), By End User (Hospitals, Chemotherapy Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Automated Compounding Device (Oncology) Market is projected to expand from USD 338.26 Million in 2025 to USD 541.87 Million by 2031, achieving a compound annual growth rate of 8.17%. These...
May 2026
192 pages
Compounding Chemotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, Supportive Care Drugs), By Route of Administration (Intravenous, Oral, Subcutaneous, Intramuscular, Intrathecal), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukemia, Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Compounding Chemotherapy Market is set to expand from USD 5.31 Billion in 2025 to USD 7.21 Billion by 2031, demonstrating a 5.23% CAGR. This market focuses on creating personalized antineop...
May 2026
180 pages
Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Squamous cell carcinoma, Adenocarcinoma, Adenosquamous carcinoma),
US$ 4,500.00
The Global Cervical Cancer Treatment Market is projected to expand significantly, growing from USD 6.98 Billion in 2025 to USD 9.42 Billion by 2031, demonstrating a compound annual growth rate (CAGR)...
May 2026
192 pages
Alpha Emitter Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Type of Radionuclide (Astatine (At-211), Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Bismuth (Bi-212), Other), By Medical Application (Prostate Cancer, Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The global alpha emitter market is projected to expand significantly, growing from USD 479.39 million in 2025 to USD 842.34 million by 2031, demonstrating a compound annual growth rate of 9.85%. This...
May 2026
182 pages
Head and Neck Squamous Cell Carcinoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Salivary Gland, Oral and Oropharyngeal, Nasal Cavity & Paranasal Sinuses, Nasopharyngeal, Laryngeal, Hypo Pharyngeal), By Treatment (Radiation, Chemotherapy, Immunotherapy), By Route of Administration (Oral, Intravenous, Others), By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Head and Neck Squamous Cell Carcinoma (HNSCC) is projected to expand significantly, rising from USD 2.49 Billion in 2025 to USD 4.09 Billion by 2031, demonstrating an 8.62% CAGR....
May 2026
180 pages
Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Diffuse Large B-cell Lymphoma (DLBCL) therapeutics is projected to expand significantly, from USD 4.82 billion in 2025 to USD 7.78 billion by 2031, demonstrating an 8.31% compoun...
May 2026
180 pages
DNA Repair Drugs Market – Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type (Alkylating Agents, PARP Inhibitors, Topoisomerase Inhibitors, Other), By Application (Neurodegenerative Diseases, Oncological, Cardiovascular Diseases, Stroke), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global DNA Repair Drugs Market is projected for significant growth, with its valuation expected to rise from USD 7.91 Billion in 2025 to USD 16.39 Billion by 2031, reflecting a robust 12.91% Compo...
May 2026
185 pages
Metastatic Colorectal Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Anti-EGFR (Epidermal Growth Factor Receptor) Inhibitors, Anti-VEGF (Vascular Endothelial Growth Factor) Therapies, Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapies, Immune Checkpoint Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for metastatic colorectal cancer drugs is projected to expand significantly, rising from USD 3.59 Billion in 2025 to USD 4.69 Billion by 2031, achieving a Compound Annual Growth Rate...
May 2026
185 pages
Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue Diethylenetriamine Pentaacetic Acid, Others), By Indication (Acute Radiation Syndrome, Chronic Radiation Syndrome), By Radiation Type (Ionizing Radiation, Non-ionizing Radiation), By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Radiation Toxicity Treatment Market, encompassing pharmaceuticals and biological agents aimed at mitigating damage to healthy tissues from ionizing radiation, predominantly from cancer radi...
May 2026
185 pages
Global Adamantinoma Treatment Market Growth 2026-2032
US$ 3,660.00
The global Adamantinoma Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Ada...
May 2026
86 pages
Global DNA Damaging Agents Market Growth 2026-2032
US$ 3,660.00
The global DNA Damaging Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for DNA Da...
May 2026
82 pages
